Boyi Biology

Changzhou Boyi Biological Group owns three major brands: Tiandi Renhe, Boyi Biology, and ACE, which are strategically positioned in different business sectors, including purification resins, core raw materials such as IVD microspheres, and scientific research reagents and instruments. After ten years of accumulation, the company has achieved 100% localization of its biological microsphere production supply chain, with core raw materials now basically produced entirely in-house. Changzhou Boyi Biotechnology Co., Ltd. is a technology-driven enterprise rooted in the in vitro diagnostics (IVD) industry, providing key raw materials and comprehensive solutions to biomedical customers. Focusing on core IVD raw materials such as diagnostic microspheres, testing reagents, and quality control materials, the company has assembled a professional team with interdisciplinary expertise in polymer material science, immunology, biomedical engineering, clinical laboratory medicine, molecular biology, and biochemistry. This has enabled the establishment of core technological advantages, advanced technical platforms, and an innovative R&D system. Upholding the vision of making the production process of IVD reagents more standardized and simpler, Changzhou Boyi is committed to the localization of core raw materials and breakthrough innovations. It provides IVD enterprises with antigen and antibody screening and expression services, testing reagent raw materials, and overall solutions, creating greater value for customers and partners.